Oligopeptide-1 is a potent cell-signaling protein that mimics the behavior of human Epidermal Growth Factor (EGF) to accelerate skin renewal and repair. This peptide stimulates the proliferation of fibroblasts and keratinocytes, leading to increased structural protein synthesis and visible anti-aging effects.
- INCI Name:
- Oligopeptide-1
- Chemical/Scientific Name:
- Recombinant Human Oligopeptide-1
- Common Aliases:
- Epidermal Growth Factor, EGF, sh-Oligopeptide-1
| Category: | Active Substances |
| Source Origin: | Biotechnological (Recombinant DNA technology using E. coli or yeast) |
| Comedogenic Rating: | 0 |
| Primary Industries: | Cosmeceuticals, Regenerative Medicine, Professional Skincare |
| Solubility: | Water-soluble |
At a Glance: Properties & Effects
| Anti-Aging/Renewal: | |
| Barrier Repair: | |
| Soothing/Calming: | |
| Irritation Risk: |
- Primary Benefits:
- Accelerates wound healing and epidermal recovery.
- Stimulates the production of Collagen and elastin.
- Improves skin density and reduces the depth of fine lines.
- Refines skin texture by promoting healthy cell turnover.
- Potential Risks:
- Potential for over-stimulation in individuals with specific skin pathologies (consult a physician).
- Degradation if formulated in highly acidic environments.
Biological Action & Cosmetic Profile
Biotechnologically engineered to mirror the 53-amino acid sequence of naturally occurring epidermal growth factors, this molecule functions as a primary messenger for cellular communication. Upon topical application, the peptide binds to the Epidermal Growth Factor Receptor (EGFR) on the surface of keratinocytes and fibroblasts. This binding triggers a signaling cascade that instructs cells to divide, migrate, and synthesize new extracellular matrix components.Dermal thickness increases as the molecule encourages the body to replenish its natural stores of structural proteins. Unlike exfoliants that force renewal through controlled damage, this signaling peptide promotes growth from the basal layers upward. Research published in the Journal of Controlled Release emphasizes its role in significantly shortening the recovery time of the skin barrier following physical or environmental trauma.Molecular stability remains a critical factor in the efficacy of such peptides. Formulations often utilize encapsulation or stabilizing agents like Glycerin and Sodium Hyaluronate to ensure the peptide survives the delivery process into the stratum corneum. Without these protective measures, the complex protein structure can easily denature, rendering the “active” portion biologically inert.
Broader Applications & Origins
The origin of growth factor research dates back to the Nobel Prize-winning discovery by Stanley Cohen and Rita Levi-Montalcini. While initially utilized in medical settings to treat chronic wounds and diabetic ulcers, the cosmetic industry adapted the technology for age-reversal and post-procedure care. Modern versions are produced via fermentation in laboratory environments, ensuring a high-purity, bio-identical substance that does not rely on human-derived tissue.
Routine Integration
- Synergies:
- Niacinamide: Enhances the barrier-strengthening effects and improves overall tone.
- Antioxidants: Combining with Ferulic Acid or Tocopherol protects the peptide from oxidative degradation.
- Hydrators: Works exceptionally well with Panthenol to soothe compromised skin.
- Conflicts:
- High-Strength Acids: Low pH environments (e.g., concentrated Glycolic Acid) may break the peptide bonds, neutralizing its signaling capability.
Clinical Consensus & Safety
The Cosmetic Ingredient Review (CIR) Expert Panel and CosIng database recognize recombinant peptides as safe for topical application in limited concentrations. Because the molecule is quite large (approximately 6,000 Daltons), systemic absorption through healthy, intact skin is negligible. Clinical trials generally show high tolerability, with almost no reports of sensitization or irritation at standard cosmetic dosages. Regulatory bodies emphasize that while growth factors are potent, recombinant versions used in skincare are distinct from human-derived materials, which are prohibited in several jurisdictions including the EU.
Is Oligopeptide-1 the same as a stem cell treatment?
No. It is a specific, purified signaling protein (growth factor) that can be found within stem cell conditioned media, but in skincare, it is typically isolated or synthetically produced for targeted action and stability.
Can this ingredient be used after chemical peels or microneedling?
Yes. Dermatologists often recommend EGF-based products post-procedure because they accelerate the repair process and support the formation of healthy new tissue.
How long does it take to see results?
While hydration effects are immediate, the structural improvements in collagen density and wrinkle reduction typically require 6 to 8 weeks of consistent, twice-daily application to align with the skin’s natural turnover cycle.